Anti-Thymocyte Globulin has 1 known drug interaction based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Belatacept. Patients taking Anti-Thymocyte Globulin should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 1
- Major
- 1
Major (1)
- Anti-Thymocyte Globulin + Belatacept— Coadministration of anti-thymocyte globulin and belatacept in de novo kidney transplant recipients may pose risk for ven…